Scientific evidence for using psychedelics to treat mental health problems has been mounting for the last decade - but researchers and patients alike have been waiting for a breakthrough. Now, scientists are poised to publish a gold-standard, double-blind randomised control trial, putting antidepessants against psilocybin, the key ingredient in magic mushrooms. Could this be the study taht brings psychedelics to the NHS?